Morphine

Nationwide Morphine Recall Lawsuits

June 9, 2008 ETHEX Corporation announced that it has voluntarily recalled a single lot of morphine sulfate 60 mg extended release tablets (Lot No. 91762) due to a report of a tablet with twice the appropriate thickness. Oversized tablets may contain as much as two times the labeled level of active morphine sulfate.

In related news, on April 25, 2008, Actavis Totowa (formerly known as Amide Pharmaceutical, Inc.) issued a Class I recall on the Digitek tablets because there is a possibility that tablets with twice the appropriate thickness might have been commercially released. These tablets may contain twice the approved level of active ingredient than it intended.

What are Morphine Sulfate Tablets?

Morphine sulfate extended-release tablets are an extended-release tablet containing morphine sulfate. Following oral administration of a given dose of morphine, the amount ultimately absorbed is essentially the same whether the source is morphine sulfate extended-release tablets or a conventional formulation. Morphine is released from this product somewhat more slowly than from conventional oral preparations.

Morphine sulfate extended-release tablets are indicated for the relief of moderate to severe pain. It is intended for use in patients who require repeated dosing with potent opioid analgesics over periods of more than a few days.

Why were the Morphine Tablets Recalled?

The voluntary single-lot recall is due to a report that a tablet with as much as double the appropriate thickness was identified and the possibility therefore that there may be other similar oversized tablets that may have been commercially released in the affected lot. Such tablets may contain as much as twice the labeled level of active morphine ingredient. The product is a white oval tablet with “60″ on one side, and “E” on the reverse.

Signs of Morphine Tablet Overdose

Opioids such as morphine have life-threatening consequences if overdosed. Those consequences can include:

• respiratory depression (difficulty or lack of breathing)
• low blood pressure
• death

Read More: ETHEX Corporation Voluntarily Recalls a Single Lot of Morphine Sulfate 60 mg Extended Release Tablets Due to the Potential for Oversized Tablets

Morphine Recall LAWSUIT - KNOW YOUR LEGAL RIGHTS

If you or somebody you know has overdosed or suffered any adverse events (morphine side effects), you should contact one our morphine recall attorneys as soon as possible. Regardless of your situation, you are sure to have questions. The only way to get your questions answered is to learn your legal rights and that is where our morphine recall lawyers come in.

An experienced Mass Tort law firm can answer your questions and provide you with a free case evaluation regarding the potential to seek financial recovery through litigation. While we understand that a financial recovery will not bring back a loved one or compensate for a lifelong disability, we also urge you to exercise your right to seek legal counsel regarding your potential morphine recall lawsuit.

Please use the form below to contact one of our Mass Tort attorneys handling morphine recall claims.

FDA Issues Recall of ETHEX Morphine Sulfate Tablets

On June 9, 2008 ETHEX Corporation in coordination with the U.S. Food & Drug Administration (FDA) issued a nationwide voluntarily recall for a single lot of morphine sulfate 60 mg extended release tablets (Lot No. 91762) due to a report of a tablet with twice the appropriate thickness. Oversized tablets may contain as much as two times the labeled level of active morphine sulfate. The lot was distributed by ETHEX Corporation under an “ETHEX” label between April 16th and April 27th of 2008. No other dosage strength, nor any other lot of the 60 mg strength is affected by this recall.

Resources

Morphine Recall - Learn more from drug side effect attorneys

FDA Announcement